Ritter Pharmaceuticals, Inc. (RTTR) financial statements (2020 and earlier)

Company profile

Business Address 1880 CENTURY PARK EAST, SUITE 1000
LOS ANGELES, CA 90067
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments21523716
Cash and cash equivalents2823716
Short-term investments 7   
Receivables00   
Prepaid expense 0000
Other undisclosed current assets1    
Total current assets:21523716
Noncurrent Assets
Operating lease, right-of-use asset0
Property, plant and equipment00000
Other noncurrent assets00000
Total noncurrent assets:10000
TOTAL ASSETS:31523716
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities26331
Accounts payable15221
Accrued liabilities01011
Debt0    
Other liabilities 0000
Total current liabilities:26331
Noncurrent Liabilities
Total liabilities:26331
Stockholders' equity
Stockholders' equity attributable to parent, including:1920415
Preferred stock  5  
Common stock00000
Additional paid in capital8072685042
Accumulated other comprehensive loss (0)   
Accumulated deficit(80)(70)(53)(45)(27)
Other undisclosed stockholders' equity attributable to parent28   
Total stockholders' equity:1920415
TOTAL LIABILITIES AND EQUITY:31523716

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues   00
Other income  (0)00
Cost of revenue
(Cost of Goods and Services Sold)
  (0)(0)(0)
Gross profit:  (0)(0)(0)
Operating expenses(11)(17)(8)(18)(9)
Other undisclosed operating income  000
Operating loss:(11)(17)(8)(18)(9)
Nonoperating income10000
Debt instrument, convertible, beneficial conversion feature  3  
Net loss attributable to parent:(10)(17)(8)(18)(9)
Preferred stock dividends and other adjustments    (0)
Net loss available to common stockholders, diluted:(10)(17)(8)(18)(9)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(10)(17)(8)(18)(9)
Other undisclosed comprehensive income (loss)0(0)   
Comprehensive loss, net of tax, attributable to parent:(10)(17)(8)(18)(9)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: